Skip to main content

Iradimed Corp

IRMD
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001325618

In the last 90 days, Iradimed Corp insiders filed 0 open-market purchases and 1 sale; 213 institutions reported holding it in 13F filings for Q2 2026, worth $750.2M in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding Iradimed Corp changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of IRMD: Q2 2023 compared with Q3 2023
MeasureQ2 2023Q3 2023Change
Holders113115+2
Shares6.14M6.08M−60.5K (−1.0%)
Value$292.9M$270.7M−$22.2M (−7.6%)

New holders (15)

Institutions that held Iradimed Corp at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to IRMD in Q3 2023
InstitutionSharesValue% of portfolio
Bridge City Capital, LLC28,172$1.25M0.63%
Ballast Asset Management, LP25,088$1.11M1.03%
Swiss National Bank16,600$736.5K0.00%
SG Capital Management LLC12,358$548.3K0.23%
Aristides Capital LLC9,200$408.2K0.27%
Winton Group Ltd8,253$366.2K0.03%
HSBC Holdings PLC5,680$251.3K0.00%
American Century Companies Inc5,251$233.0K0.00%
Credit Suisse AG5,182$229.9K0.00%
Walleye Capital LLC5,128$227.5K0.00%
Qube Research & Technologies Ltd2,765$122.7K0.00%
State of Wyoming1,585$70.3K0.02%
Gladius Capital Management LP809$35.9K0.01%
Copeland Capital Management, LLC665$29.5K0.00%
Simplex Trading, LLC294$13.0K0.00%

Sold out (13)

Institutions that held Iradimed Corp at the end of Q2 2023 and filed for Q3 2023 without it.